Bactiguard Holding AB
STO:BACTI B

Watchlist Manager
Bactiguard Holding AB Logo
Bactiguard Holding AB
STO:BACTI B
Watchlist
Price: 34.4 SEK Market Closed
Market Cap: 1.2B SEK
Have any thoughts about
Bactiguard Holding AB?
Write Note

Bactiguard Holding AB
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bactiguard Holding AB
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Bactiguard Holding AB
STO:BACTI B
Interest Income Expense
-kr29.2m
CAGR 3-Years
4%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Interest Income Expense
-kr2.8m
CAGR 3-Years
-66%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Interest Income Expense
kr159.1m
CAGR 3-Years
N/A
CAGR 5-Years
90%
CAGR 10-Years
N/A
D
Doxa AB
STO:DOXA
Interest Income Expense
-kr200.9m
CAGR 3-Years
-721%
CAGR 5-Years
-227%
CAGR 10-Years
-85%
V
Vimian Group AB
STO:VIMIAN
Interest Income Expense
-€31.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Interest Income Expense
-kr4.1m
CAGR 3-Years
-327%
CAGR 5-Years
-96%
CAGR 10-Years
N/A
No Stocks Found

Bactiguard Holding AB
Glance View

Market Cap
1.2B SEK
Industry
Health Care

Bactiguard Holding AB is a medical device company, which engages in the development and supply of infection protection solutions. The company is headquartered in Stockholm, Stockholm and currently employs 188 full-time employees. The company went IPO on 2014-06-19. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. The company consists of the noble metals: gold, palladium and silver, which reduces the adhesion of bacteria to the coated surfaces. Its product portfolio includes: BIP Foley Catherer, made from medical grade latex, and BIP Foley Catheter - Silicone, used for drainage and irrigation of the bladder; BIP Endotracheal Tube, for general anesthesia, intensive care, and emergency medicine for airway management and mechanical ventilation; and BIP Central Venous Catherer, made of polyurethane and used to administer drugs and intravenous solutions, monitor pressure and blood sampling. The firm is also present in Portugal, via a distribution agreement with Socime Medical Ltd, and Zambia.

BACTI B Intrinsic Value
28.27 SEK
Overvaluation 18%
Intrinsic Value
Price

See Also

What is Bactiguard Holding AB's Interest Income Expense?
Interest Income Expense
-29.2m SEK

Based on the financial report for Dec 31, 2023, Bactiguard Holding AB's Interest Income Expense amounts to -29.2m SEK.

What is Bactiguard Holding AB's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-13%

Over the last year, the Interest Income Expense growth was 6%. The average annual Interest Income Expense growth rates for Bactiguard Holding AB have been 4% over the past three years , -13% over the past five years .

Back to Top